Research Article

Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia

Table 3

Response to induction chemotherapy in the treatment and control groups.

VariableAML (%)ALL (%)
Treatment group ()Control group ()Treatment group ()Control group ()

CR (%)72 (81.8)58 (66.7)64 (81)51 (65.4)
CRi (%)9 (10.2)6 (6.9)7 (8.9)3 (3.8)
ORR (%)81 (92)64 (73.6)71 (89.9)54 (69.2)

Notes: AML: acute myeloid leukemia, ALL: acute lymphocytic leukemia, CR: complete remissions, CRi: CR with incomplete blood count recovery, and ORR: overall response rate. Compared with the control group, .